CSIMarket
 


Genetic Technologies Limited  (GENE)
Other Ticker:  
 

Genetic Technologies Limited Profitability Comparisons

Select each Category to receive further Information


GENE Profitability Ratio

Company Industry Sector S&P 500
Gross Margin (Q2 MRQ) -985.78 % 60.84 % 49.75 % 45.51 %
Gross Margin (Q2 TTM) -985.78 % 63.83 % 50.65 % 61.73 %
Gross Margin 5 Yr. Avg. - 47.1 % 39.64 % 37.47 %
EBITDA Margin (Q2 MRQ) -25253.91 % 12.65 % 13.78 % 17.72 %
EBITDA Margin (Q2 TTM) -25253.91 % 17.23 % 16.31 % 26.59 %
EBITDA Margin 5 Yr. Avg. - 15.09 % 13.84 % 15.44 %
Operating Margin (Q2 MRQ) -18303.32 % 10.93 % 11.06 % 16.21 %
Operating Margin (Q2 TTM) -18303.32 % 14.23 % 12.74 % 21.99 %
Operating Margin 5 Yr. Avg. - 12.76 % 9 % 12.53 %
Pre-Tax Margin (Q2 MRQ) -25253.91 % 5.68 % 7.31 % 11.53 %
Pre-Tax Margin (Q2 TTM) -25253.91 % 10.66 % 9.63 % 17.33 %
Pre-Tax Margin 5 Yr. Avg. - 11.21 % 9.74 % 10.72 %
Net Margin (Q2 MRQ) -25253.91 % 2.91 % 5.38 % 8.86 %
Net Margin (Q2 TTM) -25253.91 % 7.54 % 7.83 % 14.16 %
Net Margin 5 Yr. Avg. - 9.03 % 8.92 % 8.84 %



Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q2 MRQ) 0 % 0.19 % 0.33 % 0.21 %
Free Cash Flow Margin (Q2 TTM) 0 % - - -
Free Cash Flow Margin 5 Yr. Avg.